2 active not recruiting, 1 completed, 1 recruiting. 2 Phase 1, 1 Not applicable, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Active not recruiting 1, Recruiting 1 |
| Not applicable | 1 | Completed 1 |
| Phase 2 | 1 | Active not recruiting 1 |
Follow Refractory Acute Leukemia of Ambiguous Lineage: new trials by email Literature Review of Refractory Acute Leukemia of Ambiguous Lineage trials Research Report on Refractory Acute Leukemia of Ambiguous Lineage
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of Revumenib in Combination With Chemotherapy for Patients Diagnosed With Relapsed or Refractory Leukemia Biospecimen Collection, Bone Marrow Aspiration, Calaspargase Pegol - Recurrent Acute Leukemia of Ambiguous Lineage, Recurrent Acute Lymphoblastic Leukemia | Phase 2 | Active not recruiting | Children's Oncology Group | 78 | 2024-01-08 | 2026-08-25 |
| Study of Selinexor and Venetoclax in Combination With Chemotherapy in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia Venetoclax, Selinexor, Cytarabine - Acute Leukemia of Ambiguous Lineage in Relapse, Acute Myeloid Leukemia, in Relapse | Phase 1 | Active not recruiting | St. Jude Children's Research Hospital | 37 | 2021-11-15 | 2026-10-06 |
| CLAG-M or FLAG-Ida Chemotherapy and Reduced-Intensity Conditioning Donor Stem Cell Transplant for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelomonocytic Leukemia Cladribine, Cyclophosphamide, Cyclosporine - Recurrent Acute Myeloid Leukemia, Recurrent Chronic Myelomonocytic Leukemia | Phase 1 | Recruiting | Fred Hutchinson Cancer Center | 120 | 2020-12-03 | 2026-09-17 |
| High Throughput Drug Sensitivity Assay and Genomics- Guided Treatment of Patients With Relapsed or Refractory Acute Leukemia Chemosensitivity Assay, Cytology Specimen Collection Procedure, Gene Expression Analysis - Recurrent Acute Leukemia of Ambiguous Lineage, Recurrent Acute Lymphoblastic Leukemia | Not applicable | Completed | University of Washington | 34 | 2015-09-11 | 2022-06-30 |
Leukemia, Biphenotypic, Acute (4) · Leukemia, Myeloid, Acute (3) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (2) · Leukemia, Myelomonocytic, Chronic (1) · Myelodysplastic Syndromes (1)
Hematologic Diseases (4) · Hemic and Lymphatic Diseases (4) · Immune System Diseases (4) · Immunoproliferative Disorders (4) · Leukemia (4) · Leukemia, Lymphoid (4) · Lymphatic Diseases (4) · Lymphoproliferative Disorders (4) · Neoplasms (4) · Neoplasms by Histologic Type (4) · Leukemia, Myeloid (3) · Bone Marrow Diseases (1) · Chronic Disease (1) · Disease Attributes (1) · Myelodysplastic-Myeloproliferative Diseases (1)
Cytarabine (3) · Filgrastim (2) · Granulocyte Colony-Stimulating Factor (2) · Methotrexate (2) · fludarabine (2) · fludarabine phosphate (2) · Asparaginase (1) · Cladribine (1) · Cyclophosphamide (1) · Cyclosporine (1) · Cyclosporins (1) · Gene Expression Profiling (1) · Genetic Variation (1) · Hematopoietic Stem Cell Transplantation (1) · Hydrocortisone (1)
Children's Oncology Group (1) · Fred Hutchinson Cancer Center (1) · St. Jude Children's Research Hospital (1) · University of Washington (1)
United States (4) · Canada (1)
Filippo Milano (1) · Kelly E Faulk (1) · Mary-Elizabeth Percival (1) · Seth Karol, MD (1)
P30CA015704 (2), U10CA180886 (1)